首页> 美国卫生研究院文献>Biomedical Reports >Percutaneous transhepatic obliteration and percutaneous transhepatic sclerotherapy for intractable hepatic encephalopathy and gastric varices improves the hepatic function reserve
【2h】

Percutaneous transhepatic obliteration and percutaneous transhepatic sclerotherapy for intractable hepatic encephalopathy and gastric varices improves the hepatic function reserve

机译:经皮肝穿刺封堵术和经皮肝硬化疗法治疗顽固性肝性脑病和胃静脉曲张可改善肝功能储备

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Percutaneous transhepatic obliteration (PTO) and percutaneous transhepatic sclerotherapy (PTS) are widely performed as an emergency measure in cases of variceal hemorrhage and intractable hepatic encephalopathy. The PTO/PTS technique is capable of directly blocking the blood supply in cases in which balloon-occluded retrograde transvenous obliteration (B-RTO) is not effective, or in cases with complicated collateral flow. Although PTO/PTS is not currently the first choice due to the invasiveness of transhepatic puncture, this procedure can modify the blood flow in an antegrade manner. The present study examined the changes in hepatic function reserve following PTO/PTS for intractable hepatic encephalopathy and/or gastric varices. In total, the study included 37 patients (mean age, 61.75±12.77 years; age range, 32–88 years; male to female ratio, 23:14) with a variety of gastrorenal shunts, or B-RTO-intractable hepatic encephalopathy and gastric varices without gastrorenal shunts. The patients underwent PTO/PTS by embolizing a microcoil or injection of a sclerosing agent (5% ethanolamine oleate iopamidol). Alterations in hepatic function reserve prior to and following the procedure were compared. The patients were treated for hepatic encephalopathy in 11 patients, gastric varices in 19 patients, and both conditions in 7 patients. The results indicated that the blood ammonia level improved from 135.76±75.23 mg/dl to 88.00±42.16 and 61.81±33.75 mg/dl at 3 and 6 months after therapy, respectively. In addition, the Child-Pugh score improved from 8.48±2.01 prior to therapy to 7.70±1.84 and 7.22±2.01 at 3 and 6 months after the procedure, respectively. Although there was a concern that PTO/PTS may cause complications due to an increase in portal venous pressure (PVP) arising from shunt occlusion, no severe complications were observed. In conclusion, for patients with various gastrorenal shunts or those with B-RTO-intractable hepatic encephalopathy and gastric varices without gastrorenal shunts, PTO/PTS can improve the antegrade blood flow to the liver, as demonstrated by improvement in the hepatic function reserve.
机译:经皮肝穿刺闭塞术(PTO)和经皮肝硬化治疗(PTS)被广泛用作静脉曲张出血和顽固性肝性脑病的紧急措施。在球囊闭塞的逆行静脉闭塞术(B-RTO)无效的情况下,或在复杂的侧支流情况下,PTO / PTS技术能够直接阻断血液供应。尽管由于经肝穿刺的侵袭性,目前PTO / PTS并不是首选,但该程序可以顺行地改变血流。本研究检查了顽固性肝性脑病和/或胃底静脉曲张的PTO / PTS后肝功能储备的变化。总的来说,该研究包括37例患有各种胃肾分流或B-RTO难治性肝性脑病的患者(平均年龄61.75±12.77岁;年龄范围32-88岁;男女比例23:14)。没有胃肾分流的胃静脉曲张。患者通过栓塞微线圈或注射硬化剂(5%乙醇胺油酸酯碘帕醇)进行PTO / PTS。比较了手术前后肝功能储备的变化。该患者接受肝性脑病治疗11例,胃静脉曲张治疗19例,两种情况均治疗7例。结果表明,在治疗后3个月和6个月,血氨水平分别从135.76±75.23 mg / dl提高到88.00±42.16和61.81±33.75 mg / dl。此外,Child-Pugh评分从治疗前的8.48±2.01分别提高到术后3个月和6个月的7.70±1.84和7.22±2.01。尽管有人担心分流阻塞会导致门静脉压力(PVP)升高,但PTO / PTS可能会引起并发症,但未观察到严重的并发症。总之,对于具有各种胃肠道分流的患者或患有B-RTO顽固性肝性脑病和无胃肠道分流的胃静脉曲张的患者,PTO / PTS可以改善流向肝脏的顺行血流,这可以通过改善肝功能储备来证明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号